The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it ...

Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

Faizah Alabi is a Nigerian US-based PhD student at the Texas Tech University Health Center in the United States, where she researches ways to treat leukaemia. As a pharmaceutical scientist in the ...

Tonix Pharmaceuticals Holding Corp.'s TNX-102 SL faces an FDA decision by August 2025. Click here to read an analysis of TNXP ...

Although the FDA has rejected Stealth’s new drug application for Barth syndrome candidate elamipretide, the agency identified ...

The FDA has accepted for priority review the new drug application for sevabertinib (BAY 2927088) to treat certain patients with NSCLC.

The firm submitted data showing that more than 70 percent of patients with HER2-mutated NSCLC who hadn't received anti-HER2 therapy responded to sevabertinib.

Instead, Stealth submitted a new drug application seeking approval of elamipretide, and the FDA issued its refusal-to-file ...

Researchers engineered a new therapeutically enhanced, naturally derived particle for powerful gene therapies to tackle our ...

Cardiovascular disease and kidney disease are two of the most urgent issues in global public health. In the United States ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...